Cancer Immunotherapy by Delivering Class II MHC Antigens Using a VLP-Replicon
Technology
E-050-2014
Patent ID
E-050-2014-0-IN-11
Country
IN
Application Type
National Stage
Patent Status
Issued
Patent Number
Publication Number
36/2016
Application Number
201617023312
IC
NCI
Date Filed
Date Issued
Patent PDF